The British Columbia Investment Management Corp. is selling its interest in a window covering company.
The BCI and its co-owner AEA Investors Ltd. signed a definitive agreement to sell Springs Window Fashions to Clearlake Capital Group. Under the terms of the deal, Springs’ chief executive Eric Jungbluth will continue to lead the company following the transfer of ownership.
The BCI has co-owned the Wisconsin-based supplier of blinds, shades, specialty window treatments and hardware since 2018. Earlier this year, the BCI and AEA Investors supported a move by Clearlake to acquire a major European competitor, B&C International Inc.
In other news, the Caisse de dépôt et placement du Québec is a minority investor in an Ontario-based education technology company.
The Quebec-based organization joined in the US$300 million ($376 million) Series D funding round for Apply Board. Following the conclusion of the round, the company valuation reached US$3.2 billion ($4.1 billion).
Read: Ontario Teachers’, PSP, IMCO investing in net-zero fund, Caisse in medtech fund
ApplyBoard, which operates the worlds most widely-used digital education platform, will use the funds to continue connecting international students, academic institutions, recruitment partners and governments, according to a press release.
The Public Sector Pension Investment Board and Aviva are jointly acquiring four offices in the heart of London.
Located in a part of the city’s East End technology cluster, which is commonly referred to as Tech City, the four offices have a combined area of about 5,000 square metres. With all four buildings within easy walking distance from one another, the offices are expected to serve as a single campus for organizations renting the space.
This is the fifth real estate co-investment made between the PSP and Aviva since 2015. In 2019, the two organizations invested in a £250 million ($436 million) commercial real estate development project in Cambridge, England.
Read: CPPIB invests in India’s top e-commerce company, Caisse in India’s bio-tech labs